the new oral drug Dificid (fidaxomicin) for Clostridium difficile diarrhea
Reps will promote that the new oral drug Dificid (fidaxomicin) for Clostridium difficile diarrhea is superior to oral vancomycin.
That's because Dificid works at least as well as vanco to control C. diff...but seems to have a lower risk of recurrence.
There's one less recurrence within one month for every 10 patients treated with Dificid instead of oral vancomycin.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote